Results 271 to 280 of about 95,754 (365)

Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 2, Page 495-502, February 2026.
Abstract Extraintestinal manifestations (EIMs) manifest in 6%‐47% of patients with inflammatory bowel disease (IBD). Here, we characterize the course of EIMs in pediatric patients receiving vedolizumab included in the VedoKids cohort study. This was a subgroup analysis of the pediatric VedoKids cohort, a multicenter, prospective study of children (aged
Giulia D'Arcangelo   +11 more
wiley   +1 more source

The Efficacy and Safety of Seladelpar for Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. [PDF]

open access: yesJGH Open
Abuelazm M   +7 more
europepmc   +1 more source

The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives. [PDF]

open access: yesJ Pers Med
Romeo M   +10 more
europepmc   +1 more source

Hepatopulmonary syndrome in children and adolescents with portal hypertension in Brazil: A multicenter study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 2, Page 366-373, February 2026.
Abstract Objectives To describe the clinical and laboratory characteristics and outcomes of pediatric hepatopulmonary syndrome (HPS) secondary to portal hypertension (PH) in Brazil. Methods Fifty‐four pediatric patients diagnosed with PH and HPS according to the European Respiratory Society criteria were included in this multicenter retrospective study.
Leticia Drumond Alberto   +14 more
wiley   +1 more source

Liver homotransplantation [PDF]

open access: yes, 1986
Iwatsuki, S, Shaw, BW, Starzl, TE
core  

Orthotopic liver transplantation in the mouse [PDF]

open access: yes, 1991
Demetris, AJ   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy